You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Poster Tours
AxSpA: About treatments and outcomes
POS0306 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS REFRACTORY TO BIOLOGIC THERAPY: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
Free

 

Online download statistics by month:

Online download statistics by month: May 2022 to August 2024

AbstractFullPdf
May 20222100
Jun 2022465056
Jul 2022352057
Aug 2022172032
Sep 2022105010
Oct 20227206
Nov 20224608
Dec 202256013
Jan 202364012
Feb 20236809
Mar 20235008
Apr 202380024
May 202381013
Jun 20235807
Jul 202389016
Aug 20233106
Sep 202353015
Oct 20234208
Nov 202353019
Dec 202379010
Jan 20243203
Feb 20241704
Mar 20243609
Apr 202439014
May 20242607
Jun 202452011
Jul 20243109
Aug 20243405
Total23040391